In addition, loxoribine (an agonist of TLR7) increased the IFN-α production in PBMCs pretreated with IFN-β, suggesting that the activation of TLR7 induces the production of type I IFN in multiple sclerosis. The gene discussed is IFNB1; the disease is multiple sclerosis.